Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Regulation of FGF receptor-2 expression by transcription factor E2F-1

Oncogene volume 22, pages 5630–5635 (2003)Cite this article

Abstract

Fibroblast growth factors (FGF) and their receptors play an important role in cell proliferation, angiogenesis and embryonal development. In this study, we show that expression of the FGF receptor-2 (FGFR-2) protein is induced in the mid-to-late G1 phase of the cell cycle in serum-starved mouse NIH3T3 cells released from starvation. Transcription of mouse FGFR-2 was activated by E2F-1. Analysis of various mouse FGFR-2 promoter mutant constructs showed that a sequence located +57/+64 downstream of the transcriptional initiation site, related to the consensus E2F-responsive sequence, is necessary for the activation. The promoter activity of the mouse FGFR-2 gene is also positively regulated by E2F-2 and E2F-3, but not by E2F-4 and E2F-5. Moreover, the E2F-1-induced activation of mouse FGFR-2 gene transcription is suppressed by pRB. Taken together, the results demonstrate that FGFR-2 is a new class of targets for E2F, and expression of mouse FGFR-2 in mid-to-late G1 phase would be mediated, at least in part, by the activation of a pRB/E2F pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Avivi A, Skorecki K, Yayon A and Givol D . (1992). Oncogene, 7, 1957–1962.

  • Black AR and Azizkhan-Clifford J . (1999). Gene, 237, 281–302.

  • Botz J, Zerfass-Thome K, Spitkovsky D, Delius H, Vogt B, Meilers M, Hatzigeorgiou A and Jansen-Durr P . (1996). Mol. Cell. Biol., 16, 3401–3409.

  • DeGregori J, Leone G, Miron A, Jakoi L and Nevins JR . (1997). Proc. Natl. Acad. Sci. USA, 94, 2443–2452.

  • Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A, Sardet C and Weinberg RA . (1996). Oncogene, 12, 1173–1180.

  • Grana X, Garriga J and Mayol X . (1998). Oncogene, 17, 3365–3383.

  • Helin K, Wu CL, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C and Harlow E . (1993). Genes Dev., 7, 1850–1861.

  • Johnson DE, Lee PL, Lu J and Williams LT . (1990). Mol. Cell. Biol., 10, 4728–4736.

  • Johnson DE and Williams LT . (1993). Cancer Res., 60, 1–41.

  • Johnson DG, Schwarz JK, Cress WD and Nevins JR . (1993). Nature, 365, 349–352.

  • Jones SM and Kazlauskas A . (2001). Nature Cell Biol., 3, 165–172.

  • Kovesdi I, Reichel R and Nevins JR . (1986). Cell, 45, 219–228.

  • Lukas J, Bartkova J and Bartek J . (1996). Mol. Cell. Biol., 16, 6917–6925.

  • Ohtani K, DeGregori J and Nevins JR . (1995). Proc. Natl. Acad. Sci. USA, 92, 12146–12150.

  • Peters KG, Ornitz D, Werner S and Williams LT . (1993). Dev. Biol., 155, 423–430.

  • Powers CJ, McLeskey SW and Wellstein A . (2000). Endocr. Relat. Cancer, 7, 165–197.

  • Qin XQ, Livingston DM, Ewen M, Sellers WR, Arany Z and Kaelin Jr WG . (1995). Mol. Cell. Biol., 15, 742–755.

  • Ricol D, Cappellen D, El Marjou A, Gil-Diez-de-Medina S, Girault JM, Yoshida T, Ferry G, Tucker G, Poupon MF, Chopin D, Thiery JP and Radvanyi F . (1999). Oncogene, 18, 7234–7243.

  • Stark KL, McMahon JA and McMahon AP . (1991). Development, 113, 641–651.

  • Takahashi Y, Rayman JB and Dynlacht BD . (2000). Genes Dev., 14, 804–816.

  • Tashiro E, Maruki H, Minato Y, Doki Y, Weinstein IB and Imoto M . (2003). Cancer Res., 63, 424–431.

  • Yamazaki L . (1998). Results Probl. Cell Differ., 22, 199–227.

  • Zhang Y and Chellappan SP . (1995). Oncogene, 10, 2085–2093.

Download references

Acknowledgements

We thank Dr WG Kaelin Jr for supplying HA-tagged E2F-1, HA-tagged E2F-1 (1-368), HA-tagged E2F-1(132E) and HA-tagged E2F-4 cDNA plasmids. We are also grateful to Dr J Magae for supplying HA-tagged E2Fs-2, -3, -5 cDNAs and pRB and p130 cDNA plasmids. This study was partly supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Author information

Authors and Affiliations

  1. Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, Yokohama, 223-8522, Japan

    Etsu Tashiro, Yusuke Minato, Hiroko Maruki, Masataka Asagiri & Masaya Imoto

Authors
  1. Etsu Tashiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yusuke Minato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroko Maruki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masataka Asagiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masaya Imoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masaya Imoto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tashiro, E., Minato, Y., Maruki, H. et al. Regulation of FGF receptor-2 expression by transcription factor E2F-1. Oncogene 22, 5630–5635 (2003). https://doi.org/10.1038/sj.onc.1206636

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206636

Keywords

This article is cited by

Search

Advanced search

Quick links